Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 32.06
0.945 %
$ 1.79 B
Market Cap
24.29
P/E
Price Target
Average
20.87%
Revenue Forecast
Estimate
12.20%
EBIT
Estimate
233.75%
Net Income
Estimate
459.39%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Supernus Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for SUPN of $38.8 , with forecasts ranging from
a
low of
$36 to a high of $41 .
SUPN Lowest Price Target
Wall Street Target
36 USD
12.29%
SUPN Average Price Target
Wall Street Target
38.8 USD
20.87%
SUPN Highest Price Target
Wall Street Target
41 USD
27.89%
REVENUE FORECAST
Revenue Forecast Chart SUPN
EBIT FORECAST
EBIT Forecast Chart SUPN
NET INCOME FORECAST
Net Income Chart SUPN